← All Sponsors
SPONSOR

Entrada Therapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Duchenne Muscular Dystrophy (DMD)
NCT07038824 Phase 1, Phase 2
Recruiting

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45

Duchenne Muscular Dystrophy (DMD)
Belgium, Italy, Netherlands View Trial →